RTTNews | May 11, 2021 09:47AM EDT

09:46 Tuesday, May 11, 2021 (RTTNews.com) - Alexion Pharmaceuticals Inc. (ALXN) said that its shareholders have approved proposed acquisition by AstraZeneca Plc. (AZN.L, AZN). The acquisition is expected to close in the third quarter of 2021.

In December 2020, AstraZeneca agreed to buy Alexion for $175 per share in cash and stock, valuing the Boston-based company at $39 billion.

As per the terms of the deal, Alexion shareholders would receive $60 in cash and 2.1243 AstraZeneca American Depositary Shares or ADSs for each Alexion share.

Read the original article on RTTNews ( https://www.rttnews.com/3193821/alexion-pharma-shareholders-approve-acquisition-by-astrazeneca.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2021 RTTNews.com All Rights Reserved